IP Library Granted Patent US 9,873,746
Granted Patent B2
US 9,873,746 · App. 13/070,583 · Granted Jan 23, 2018

Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,873,746
App. No.
13/070,583
Granted
Jan 23, 2018
Kind
B2
Abstract

Methods are provided for the synthesis and secretion of recombinant proteins preferably large mammalian proteins or hetero-multimeric proteins at high levels and for prolonged time in polyploid, preferably diploid yeast. These methods use various mating competent yeast, including Pichia . In a preferred embodiment, a first expression vector is transformed into a first haploid cell; and a second expression vector is transformed into a second haploid cell. The transformed haploid cells, each individually synthesizing a non-identical polypeptide, are identified and then genetically crossed or fused. The resulting diploid strains are utilized to produce and secrete fully assembled and biologically functional hetero-multimeric protein.

Claims (9)

1. A diploid Pichia pastoris yeast culture which is cultured under conditions whereby the diploid Pichia pastoris yeast culture expresses and secretes into the culture medium a heterologous multichain polypeptide encoded by one or more heterologous DNAs operably linked to a promoter, wherein said one or more heterologous DNAs are expressed by diploid Pichia pastoris yeast cells comprised in said diploid Pichia yeast culture, wherein the heterologous multichain polypeptide is other than an antibody or antibody fragment that specifically binds to a target antigen,

wherein the density of Pichia pastoris in the culture is at least 100 g/L.

2. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 200 g/L.

3. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 300 g/L.

4. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 400 g/L.

5. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 500 g/L.

6. The diploid Pichia pastoris yeast culture of claim 1 wherein said one or more heterologous DNAs are comprised on a plasmid.

7. The diploid Pichia pastoris yeast culture of claim 1 wherein said one or more heterologous DNAs are integrated into the chromosomal DNA of said yeast.

8. The diploid Pichia pastoris yeast culture of claim 1 , wherein the heterologous polypeptide is selected from the group consisting of a hormone, growth factor, cytokine, lymphokine, enzyme, receptor, cytotoxin, lymphotoxin, immunotoxin, and a tumor polypeptide.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 054161 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →
CHANGE OF NAME Recorded Sep 3, 2020
From: ALDER BIOPHARMACEUTICALS, INC
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
Reel/Frame 053681/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: ALDERBIO HOLDINGS LLC
To: H. LUNDBECK A/S
Reel/Frame 053020/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2014
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032289/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2014
From: CREGG, JAMES M.; LATHAM, JOHN; LITTON, MARK; SCHATZMAN, RANDALL; TOLSTORUKOV, ILYA I
To: KECK GRADUATE INSTITUTE; ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032172/0723 →